Sarepta Therapeutics
SRPT
SRPT
394 hedge funds and large institutions have $8.05B invested in Sarepta Therapeutics in 2023 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 123 increasing their positions, 139 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
12% less repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 139
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
20% less capital invested
Capital invested by funds: $10.1B → $8.05B (-$2.04B)
Holders
394
Holding in Top 10
7
Calls
$655M
Puts
$362M
Top Buyers
| 1 | +$281M | |
| 2 | +$184M | |
| 3 | +$80.3M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$66M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$51M |
Top Sellers
| 1 | -$319M | |
| 2 | -$97.8M | |
| 3 | -$67.9M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$67.6M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$56.3M |